Vancomycin

Overview

Vancomycin is a glycopeptide antibiotic used to treat serious bacterial infections by inhibiting bacterial cell wall synthesis. It is particularly effective against Gram-positive bacteria, including resistant strains like MRSA.

API suppliers (21)

Suppliers of Vancomycin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Xellia Pharmaceuticals ApSDenmark3 active DMF
• LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD2 active DMF
• HospiraUnited States1 active DMF
• Lek Pharmaceuticals D.D.Slovenia1 active DMF
• HospiraUnited States1 active DMF
• Lek Pharmaceuticals D.D.Slovenia1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• Lek Pharmaceuticals D.D.Slovenia1 active DMF
• HospiraUnited States1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• Zhejiang Medicine Co., Ltd.China1 active DMF
• CONCORD BIOTECH LTD1 active DMF
• CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
• JIANGSU HIBROAD BIO-PHARMACEUTICAL CO LTD
• Eli Lilly and CompanyUnited States
• LEDERLE LABORATORIES
• FUJISAWA PHARMACEUTICAL CO
• CKD BIO CORPSouth
• Zhejiang Hisun Pharmaceutical Co., Ltd.China
• Pharma Co. InternationalSwitzerland

Patent & exclusivity (US)

Per the FDA Orange Book (97 approved US products), the latest listed US patent on Vancomycin expires 6 Nov 2035. Generic API sourcing typically opens up once these lapse.

Therapeutic areas